Cytogenetic Abnormalities in Neuroblastoma
Author Information
Author(s): P. Vernole, C. Concato, C. Pianca, B. Nicoletti, G. Melino
Primary Institution: Università 'Tor Vergata'
Hypothesis
The genetic changes produced by abnormalities on chromosomes 1 and 2 might be related to tumor progression.
Conclusion
The study found a correlation between increased expression of fragile site lp31-32 in the patient's lymphocytes and deletion in tumor cells.
Supporting Evidence
- Thirty-seven percent of metaphases from bone marrow aspirate showed a specific karyotype.
- Treatment with methotrexate reduced the aberrant mitoses rate to 2%.
- N-myc in situ hybridization showed significant signal on both markers confirming the cytogenetic interpretation.
- The mother presented an increased sensitivity to the inducibility of fragile sites.
Takeaway
A 15-month-old boy with neuroblastoma showed unusual genetic changes that might be linked to his cancer.
Methodology
The study involved cytogenetic analysis, immunofluorescence, and treatment with methotrexate and aphidicolin.
Limitations
The findings are based on a single case study, which limits generalizability.
Participant Demographics
The participant was a 15-month-old male with neuroblastoma.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website